These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8787892)

  • 1. Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.
    París MM; Shelton S; Trujillo M; Hickey SM; McCracken GH
    Antimicrob Agents Chemother; 1996 Jan; 40(1):122-6. PubMed ID: 8787892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Fernàndez A; Maiques JM; Tubau F; Ardanuy C; Viladrich PF; Liñares J; Gudiol F
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1907-11. PubMed ID: 12760866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
    Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
    Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.
    Friedland IR; Shelton S; Paris M; Rinderknecht S; Ehrett S; Krisher K; McCracken GH
    Pediatr Infect Dis J; 1993 Mar; 12(3):196-200. PubMed ID: 8451095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
    Arditi M; Mason EO; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL
    Pediatrics; 1998 Nov; 102(5):1087-97. PubMed ID: 9794939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
    Kim YS; Liu Q; Chow LL; Täuber MG
    Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.
    Rodriguez-Cerrato V; Ghaffar F; Saavedra J; Michelow IC; Hardy RD; Iglehart J; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3098-103. PubMed ID: 11600362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Pfister M; Acosta F; Cottagnoud M; Flatz L; Kühn F; Müller HP; Stucki A
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3928-33. PubMed ID: 15388454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
    Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
    Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
    Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
    J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ; Schutze GE; Mason EO; Kaplan SL
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.